Al Mayadeen English

  • Ar
  • Es
  • x
Al Mayadeen English

Slogan

  • News
    • Politics
    • Economy
    • Sports
    • Arts&Culture
    • Health
    • Miscellaneous
    • Technology
    • Environment
  • Articles
    • Opinion
    • Analysis
    • Blog
    • Features
  • Videos
    • NewsFeed
    • Video Features
    • Explainers
    • TV
    • Digital Series
  • Infographs
  • In Pictures
  • • LIVE
News
  • Politics
  • Economy
  • Sports
  • Arts&Culture
  • Health
  • Miscellaneous
  • Technology
  • Environment
Articles
  • Opinion
  • Analysis
  • Blog
  • Features
Videos
  • NewsFeed
  • Video Features
  • Explainers
  • TV
  • Digital Series
Infographs
In Pictures
  • Africa
  • Asia
  • Asia-Pacific
  • Europe
  • Latin America
  • MENA
  • Palestine
  • US & Canada
BREAKING
Israeli media: IOF's top lawyer hands in resignation over leak of Sde Teiman video
Al Mayadeen's correspondent: Israeli drone strike targets motorcycle in Kawnin, South Lebanon.
Hegseth in a meeting with his Chinese counterpart: Washington will continue to defend its interests vigorously
US Defense Secretary Pete Hegseth: The United States is concerned about China's activities in the South China Sea
Occupied Palestine: Israeli occupation forces demolishe residential homes east of Khan Younis city in the southern Gaza Strip
Al Mayadeen correspondent: An Israeli drone attacked the main road in the town of Harouf, South Lebanon.
Lebanese President: Israeli aggression on Blida took place in aftermath of meeting of ceasefire monitoring committee.
Lebanese President Joseph Aoun asks Commander of Lebanese Army to confront any Israeli incursion into liberated Lebanese territory in the South.
Al Mayadeen's correspondent: Israeli aircraft launch series of strikes on area of Jarmaq, South Lebanon.
Reuters: Afghanistan and Pakistan agree to restart peace talks in Istanbul.

Weight-loss drug cuts risk of heart attack, strokes: Novo Nordisk

  • By Al Mayadeen English
  • Source: Agencies
  • 9 Aug 2023 11:10
3 Min Read

This preliminary study implies that this class of weight-loss drugs can impart long-lasting improvements to cardiovascular health.

  • x
  • Photo of the former North American headquarters of Novo Nordisk, Inc., in Plainsboro, N.J. taken on April 24, 2008. (AP)
    Photo of the former North American headquarters of Novo Nordisk, Inc., in Plainsboro, N.J. taken on April 24, 2008. (AP)

In a statement released on Tuesday that sent the firm's shares leaping to a record high, Danish pharmaceutical giant Novo Nordisk claimed that the obesity medicine Wegovy reduces the risk of heart attacks and strokes by a fifth.

Even though it is preliminary, this is the first study to imply that this class of weight-loss drugs, which has garnered substantial public interest, can impart long-lasting improvements to cardiovascular health.

17,604 overweight or obese adults aged 45 participated in the research, and they were randomly assigned to receive either the injectable medication or a placebo over the course of five years.

Strokes, heart attacks, and cardiovascular deaths all decreased by 20%, according to a statement from Novo Nordisk, though the company did not provide a breakdown for each category.

Read: Mediterranean diet can reduce heart attacks, study finds

It added that it planned to file for regulatory approval to broaden the usage for Wegovy in the US and the EU in 2023. The trial's comprehensive results will be published at a scientific meeting later this year.

Related News

Study finds Ozempic good for the heart, not just weight loss

BMI metric has caused 'historical harm': AMA

On Tuesday, Novo Nordisk's stock price increased by more than 17% at market closing in Copenhagen.

"We are very excited about the results," Martin Holst Lange, the company's executive vice president for development said, adding that the drug "has the potential to change how obesity is regarded and treated".

The results were also welcomed by the medical community.

Even though the trials "still need to be confirmed through careful peer review," they still show "the urgent need for patients living with obesity to be offered this effective and safe drug to prevent future disease," according to Simon Cork, senior lecturer in physiology at Anglia Ruskin University, who did not participate in the research.

According to Naveed Sattar, a professor of metabolic medicine, the University of Glasgow, the results "are exciting as preventing heart attacks and stroke with a drug that also lowers weight is very important for many patients." He also did not take part in the research but has previously consulted for Novo Nordisk.

Wegovy and the diabetes medication Ozempic are both produced by Novo Nordisk, the largest producer of insulin in the world. In May, the company reported a 39 percent increase in first-quarter earnings, helped by sales of its obesity therapies.

The European Medicines Agency, which has its headquarters in Amsterdam, announced in mid-July that it was examining data "on the risk of suicidal thoughts and thoughts of self-harm" with respect to three well-known weight-loss medications: Saxenda, Wegovy, and Ozempic. The last two both contain the active ingredient semaglutide.

Among more than a billion people worldwide suffering from obesity, according to the World Health Organization, there is intense competition among pharmaceutical companies to develop effective therapies.

  • overweight
  • stroke patients
  • Denmark
  • heart failure
  • obesity
  • Novo Nordisk

Most Read

Arab League chief exposes secret US deal shielding 'Israel’s' nukes

Arab League chief exposes secret US deal shielding 'Israel’s' nukes

  • Politics
  • 27 Oct 2025
Hi-tech holocaust: Microsoft’s role in Gaza genocide

Microsoft's role in world’s first AI-driven genocide, in Gaza, exposed

  • Technology
  • 28 Oct 2025
What Marr evidently didn't seem to understand was that Hedges isn't saying that Western journalists manipulate the truth, but that they systematically amplify Israeli narratives they know are false. (Al Mayadeen English; Illustrated by Batoul Chamas)

Western journalists know they have a case to answer for their betrayal of Gaza, and it frightens them

  • Opinion
  • 24 Oct 2025
Sheikh Naim Qassem speaks during an interview with Al-Manar TV, October 26, 2025 (Screenshot)

Hezbollah ready to face 'Israel' in case of war: Sheikh Naim Qassem

  • Politics
  • 27 Oct 2025

Coverage

All
War on Gaza

Read Next

All
ap
Politics

Hamas calls on int’l community to act against Israeli settlement plan

In this Nov. 9, 2017, file photo, U.S. President Donald Trump, right, chats with Chinese President Xi Jinping during a welcome ceremony at the Great Hall of the People in Beijing. (AP)
Economy

Ex-US diplomat says Trump-Xi deal 'tactical retreat', not lasting deal

An unarmed Minuteman II intercontinental ballistic missile launches from Vandenberg Air Force Base, California, during a test in 2002. (US Air Force)
Politics

JD Vance defends Trump's nuclear test plan as 'crucial for security'

Ultra-Orthodox Jews attend the "million man" protest against military conscription, in occupied al-Quds, October 30, 2025 (AFP)
Politics

Haredi mass rally in al-Quds exposes Zionist regime's growing crisis

Al Mayadeen English

Al Mayadeen is an Arab Independent Media Satellite Channel.

All Rights Reserved

  • x
  • Privacy Policy
  • About Us
  • Contact Us
  • Authors
Android
iOS